ICU Medical, Inc. (ICUI)

ICU Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,382	2,259	2,280	1,316	1,271
Revenue	2,382	2,259	2,280	1,316	1,271
Revenue Growth (YoY)	5.44%	-0.92%	73.21%	3.56%	0.38%
Cost of Revenue	1,557	1,519	1,582	824.82	809.51
Gross Profit	824.78	739.87	697.76	491.49	461.5
Selling, General & Admin	638.76	606.69	608.35	302.58	283.95
Research & Development	88.62	85.34	92.98	47.5	42.95
Operating Expenses	727.38	692.04	701.33	350.08	326.9
Operating Income	97.41	47.84	-3.57	141.41	134.6
Interest Expense	-106.54	-102.73	-70.81	-0.86	-1.75
Interest & Investment Income	10.79	7.51	4.43	2.84	3.68
Currency Exchange Gain (Loss)	-9.79	-5.92	-5.78	-1.02	-
Other Non Operating Income (Expenses)	-4.92	-2.43	3.2	0.63	2.81
EBT Excluding Unusual Items	-13.06	-55.74	-72.53	143	139.33
Merger & Restructuring Charges	-59.84	-41.26	-71.42	-18.04	-28.41
Gain (Loss) on Sale of Assets	-1.61	-0.15	-2.55	-1.65	1.77
Other Unusual Items	5.4	16.25	32.09	-0.13	-15.2
Pretax Income	-66.01	-78.3	-114.41	123.19	97.49
Income Tax Expense	51.68	-48.64	-40.12	20.05	10.62
Net Income	-117.69	-29.66	-74.29	103.14	86.87
Net Income to Common	-117.69	-29.66	-74.29	103.14	86.87
Net Income Growth	-	-	-	18.72%	-14.02%
Shares Outstanding (Basic)	24	24	24	21	21
Shares Outstanding (Diluted)	24	24	24	22	22
Shares Change (YoY)	1.23%	0.93%	9.58%	0.88%	0.21%
EPS (Basic)	-4.83	-1.23	-3.11	4.86	4.16
EPS (Diluted)	-4.83	-1.23	-3.11	4.74	4.02
EPS Growth	-	-	-	17.91%	-14.29%
Free Cash Flow	124.66	82.31	-152.44	199	130.75
Free Cash Flow Per Share	5.11	3.42	-6.39	9.14	6.06
Gross Margin	34.63%	32.75%	30.60%	37.34%	36.31%
Operating Margin	4.09%	2.12%	-0.16%	10.74%	10.59%
Profit Margin	-4.94%	-1.31%	-3.26%	7.83%	6.83%
Free Cash Flow Margin	5.23%	3.64%	-6.69%	15.12%	10.29%
EBITDA	316.92	276.61	231.58	231.11	220.23
EBITDA Margin	13.30%	12.24%	10.16%	17.56%	17.33%
D&A For EBITDA	219.51	228.77	235.15	89.7	85.63
EBIT	97.41	47.84	-3.57	141.41	134.6
EBIT Margin	4.09%	2.12%	-0.16%	10.74%	10.59%
Effective Tax Rate	-	-	-	16.28%	10.90%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q